Door-to-needle initiative associated with more timely tPA administration, better outcomes in acute ischemic stroke | ACP Hospitalist Weekly | ACP Hospitalist
A door-to-needle initiative improved administration of tissue plasminogen activator (tPA) and clinical outcomes, including in-hospital mortality, according to a new study.
Now that endovascular therapy has been officially endorsed by experts, how should hospitals respond?
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
AHA/ASA guidelines on acute ischemic stroke expand thrombectomy window | ACP Hospitalist Weekly | ACP Hospitalist
The guidelines address prehospital stroke care, urgent and emergency evaluation and treatment with IV and intraarterial therapies, and in-hospital management, including secondary prevention measures.
Challenges of moving latest research into practice.
Endovascular therapy not superior to IV tPA for acute ischemic stroke | ACP Hospitalist Weekly | ACP Hospitalist
For patients with acute ischemic stroke, endovascular therapy isn't superior to standard treatment with intravenous tissue plasminogen activator (IV tPA), a study found.
Alteplase treatment associated with slightly improved long-term survival after ischemic stroke | ACP Hospitalist Weekly | ACP Hospitalist
Patients randomized to alteplase in addition to standard care had a significantly higher mortality rate during the first 7 days after treatment, but a significantly lower risk of death between 8 days and 3 years after treatment.
Summaries from ACP Hospitalist Weekly.
Most ischemic stroke readmissions aren't preventable, study suggests | ACP Hospitalist Weekly | ACP Hospitalist
Only a small proportion of ischemic stroke readmissions are preventable, a new study found.
An academic medical center reduces door-to-needle time dramatically.